FRANKLIN RESOURCES INC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 246 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
FRANKLIN RESOURCES INC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$190,251
-22.7%
19,756
-14.6%
0.00%
Q2 2023$246,178
+2.6%
23,137
+1.4%
0.00%
Q1 2023$240,003
-3.2%
22,814
+14.0%
0.00%
Q4 2022$247,999
+17.5%
20,016
-1.4%
0.00%
Q3 2022$211,000
+29.4%
20,307
+43.2%
0.00%
Q2 2022$163,000
+7.9%
14,184
+17.9%
0.00%
Q1 2022$151,000
+29.1%
12,031
+19.1%
0.00%
Q4 2021$117,00010,0980.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$172,422,80022.05%
13D Management LLC 533,562$5,613,0732.85%
Quantedge Capital Pte Ltd 541,200$5,693,4242.22%
Price Jennifer C. 520,000$5,470,4001.74%
Tamarack Advisers, LP 210,000$2,209,2000.81%
Intrinsic Value Partners, LLC 51,605$542,8850.73%
Brown Capital Management 3,933,933$41,384,9750.62%
Old West Investment Management, LLC 75,219$791,3030.43%
EMC Capital Management 43,315$4560.38%
Hillsdale Investment Management Inc. 420,617$4,424,8910.38%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders